logo-loader

E-Therapeutics signs deal with top five global pharma company for new project

Headlines from the Proactive UK newsroom.

E-therapeutics (LON:ETX) is to work with a global, top five pharmaceutical company on a project related to neurodegenerative diseases such as Parkinson's, Alzheimer's and Huntington's. Results and the IP of the project will remain the property of E-Therapeutics.

Mobile commerce group Bango (LON:BGO) has partnered with the music streaming giant Spotify. Through the tie-up, Spotify users will be able to bundle mobile and fixed subscription plans via Bango.

Iofina (LON:IOF) has confirmed its making the move into the hemp market. The iodine producer has set up a new company to grow products in Central America and the Caribbean to sell into the US and elsewhere.

TUI’s underlying profits dropped by over 50% year-on-year in its latest quarter. The holiday group’s airline operations were again hit by a very competitive market and Brexit uncertainty.

Plus500 (LON:PLUS) has taking another big hit from tighter regulation of derivatives trading. Interim revenues fell 68%, profits by 80% while the dividend was also slashed by 80%.

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of e-Therapeutics plc named herein, including the promotion by the Company of e-Therapeutics plc in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Arizona Silver Exploration Chairman Mike Stark excited about outlook for 2019

Arizona Silver Exploration (CVE:AZS) Chairman Mike Stark sat down with Steve Darling from Proactive Investors Vancouver to talk about his Chairman's letter sent out to shareholders. In it, Stark talks about the positive past year and some exciting developments for 2019. The full letter can be...

on 28/2/19

2 min read